DGPharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DGPharma
Largest movements
- Receivables within one year -€68,487
down €68,487 (-6.7%), from €1.0m to €958,876
of which Other amounts receivable: -€266,354
- Stocks and contracts +€55,168
up €55,168 (+20.4%), from €270,464 to €325,632
- Intangible fixed assets +€15,511
up €15,511 (+60.8%), from €25,526 to €41,038
- Other debts +€430,000
new in 2025: €430,000
- Reserves -€271,202
down €271,202 (-99.8%), from €271,787 to €586
- Trade debts -€217,775
down €217,775 (-31.1%), from €700,871 to €483,096
- Tax, wage and social debts +€48,493
up €48,493 (+67.6%), from €71,734 to €120,227
of which Taxes: +€31,593
- Gross operating margin +€162,978
up €162,978 (+173.2%), from €94,120 to €257,098
- Taxes +€26,340
up €26,340 (+70.9%), from €37,175 to €63,514
- Staff costs +€20,901
new in 2025: €20,901
- Financial income -€13,514
down €13,514 (-66.6%), from €20,292 to €6,777
- Depreciation +€4,671
up €4,671 (+69.7%), from €6,702 to €11,373
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,344,393 | €1,333,909 | -€10,484 | -0.8% |
| Fixed assets | 21/28 | €25,526 | €41,038 | +€15,511 | +60.8% |
| Intangible fixed assets | 21 | €25,526 | €41,038 | +€15,511 | +60.8% |
| Current assets | 29/58 | €1,318,866 | €1,292,871 | -€25,995 | -2.0% |
| Stocks and contracts in progress | 3 | €270,464 | €325,632 | +€55,168 | +20.4% |
| Stocks | 30/36 | €270,464 | €325,632 | +€55,168 | +20.4% |
| Amounts receivable within one year | 40/41 | €1,027,362 | €958,876 | -€68,487 | -6.7% |
| Trade receivables | 40 | €36,043 | €233,910 | +€197,867 | +549.0% |
| Other amounts receivable | 41 | €991,319 | €724,966 | -€266,354 | -26.9% |
| Deferred charges and accrued income | 490/1 | €21,040 | €8,364 | -€12,676 | -60.2% |
| Total equity and liabilities | 10/49 | €1,344,393 | €1,333,909 | -€10,484 | -0.8% |
| Equity | 10/15 | €571,787 | €300,586 | -€271,202 | -47.4% |
| Contributions | 10/11 | €300,000 | €300,000 | = | 0.0% |
| Reserves | 13 | €271,787 | €586 | -€271,202 | -99.8% |
| Distributable reserves | 133 | €271,787 | €586 | -€271,202 | -99.8% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €772,606 | €1,033,324 | +€260,718 | +33.7% |
| Amounts payable within one year | 42/48 | €772,606 | €1,033,324 | +€260,718 | +33.7% |
| Trade debts | 44 | €700,871 | €483,096 | -€217,775 | -31.1% |
| Suppliers | 440/4 | €700,871 | €483,096 | -€217,775 | -31.1% |
| Taxes, remuneration and social security | 45 | €71,734 | €120,227 | +€48,493 | +67.6% |
| Taxes | 450/3 | €71,734 | €103,327 | +€31,593 | +44.0% |
| Remuneration and social security | 454/9 | - | €16,900 | +€16,900 | |
| Other amounts payable | 47/48 | - | €430,000 | +€430,000 | |
| Remuneration, social security and pensions | 62 | - | €20,901 | +€20,901 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,702 | €11,373 | +€4,671 | +69.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€11,519 | -€7,304 | +€4,215 | +36.6% |
| Other operating charges | 640/8 | €3,132 | €2,522 | -€610 | -19.5% |
| Gross operating margin | 9900 | €94,120 | €257,098 | +€162,978 | +173.2% |
| Operating profit (loss) | 9901 | €95,805 | €229,606 | +€133,800 | +139.7% |
| Financial income | 75/76B | €20,292 | €6,777 | -€13,514 | -66.6% |
| Recurring financial income | 75 | €20,292 | €6,777 | -€13,514 | -66.6% |
| Financial charges | 65/66B | €13,615 | €14,070 | +€455 | +3.3% |
| Recurring financial charges | 65 | €13,615 | €14,070 | +€455 | +3.3% |
| Profit (loss) for the period before taxes | 9903 | €102,482 | €222,313 | +€119,831 | +116.9% |
| Income taxes | 67/77 | €37,175 | €63,514 | +€26,340 | +70.9% |
| Profit (loss) for the period | 9904 | €65,307 | €158,798 | +€93,491 | +143.2% |
| Profit (loss) for the period to be appropriated | 9905 | €65,307 | €158,798 | +€93,491 | +143.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.